You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

List of Excipients in API DOPAMINE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing DOPAMINE HYDROCHLORIDE

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Baxter Healthcare Corporation DOPAMINE HYDROCHLORIDE AND DEXTROSE dopamine hydrochloride 0338-1005 DEXTROSE MONOHYDRATE
Baxter Healthcare Corporation DOPAMINE HYDROCHLORIDE AND DEXTROSE dopamine hydrochloride 0338-1005 HYDROCHLORIC ACID
Baxter Healthcare Corporation DOPAMINE HYDROCHLORIDE AND DEXTROSE dopamine hydrochloride 0338-1005 SODIUM BISULFITE
Baxter Healthcare Corporation DOPAMINE HYDROCHLORIDE AND DEXTROSE dopamine hydrochloride 0338-1005 WATER
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing DOPAMINE HYDROCHLORIDE

Company Ingredient NDC Excipient
Hikma Pharmaceuticals USA Inc dopamine hydrochloride 0143-9252 CITRIC ACID ACETATE
Hikma Pharmaceuticals USA Inc dopamine hydrochloride 0143-9252 SODIUM CITRATE
Hikma Pharmaceuticals USA Inc dopamine hydrochloride 0143-9252 SODIUM METABISULFITE
HF Acquisition Co LLC DBA HealthFirst dopamine hydrochloride 51662-1489 CITRIC ACID ACETATE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for DOPAMINE HYDROCHLORIDE

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: CITRIC ACID ACETATE

Excipient focus: DEXTROSE MONOHYDRATE

Excipient focus: HYDROCHLORIC ACID

Excipient focus: SODIUM BISULFITE

Excipient focus: SODIUM CITRATE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM METABISULFITE

Excipient focus: TRISODIUM CITRATE DIHYDRATE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group